De Ferrari, Gaetano M. 
; Maier, Lars S. ; Mont, Lluís ; Schwartz, Peter J. ; Simonis, Gregor ; Leschke, Matthias ; Gronda, Edoardo ; Boriani, Giuseppe ; Darius, Harald ; Guillamón Torán, Laura ; Savelieva, Irene ; Dusi, Veronica ; Marchionni, Niccolò ; Quintana Rendón, Miguel ; Schumacher, Kai ; Tonini, Giulia ; Melani, Lorenzo ; Giannelli, Stefano ; Alberto Maggi, Carlo ; John Camm, A.
; Maier, Lars S. ; Mont, Lluís ; Schwartz, Peter J. ; Simonis, Gregor ; Leschke, Matthias ; Gronda, Edoardo ; Boriani, Giuseppe ; Darius, Harald ; Guillamón Torán, Laura ; Savelieva, Irene ; Dusi, Veronica ; Marchionni, Niccolò ; Quintana Rendón, Miguel ; Schumacher, Kai ; Tonini, Giulia ; Melani, Lorenzo ; Giannelli, Stefano ; Alberto Maggi, Carlo ; John Camm, A. 
Abstract
BACKGROUND Currently available antiarrhythmic agents for the treatment of atrial fibrillation (AF) have important limitations, leaving an unmet need for safe and effective therapy. Ranolazine is an approved antianginal agent with a favorable safety profile and electrophysiologic properties suggesting a potential role in the treatment of AF. OBJECTIVE The purpose of this study was to assess the ...
Owner only: item control page
Altmetric